V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001067 | 330000580 | 1.71 | 85.2 | Curative (C) | 2017-03-13 | 2017-04-09 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330002675 | CISPLATIN + RT |
| 330001068 | 330000581 | null | 87.3 | Adjuvant (A) | 2016-07-21 | 2016-07-21 | Cisplatin + Radiotherapy | null | null | 330002678 | CISPLATIN + RT |
| 330001070 | 330000583 | 1.48 | 50.8 | Palliative (P) | 2016-07-04 | 2016-06-01 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 330002686 | CISPLATIN + FLUOROURACIL |
| 330001071 | 330000583 | 1.76 | 94 | Curative (C) | 2013-10-07 | 2013-10-07 | Cisplatin + Radiotherapy | 2 | null | 330002686 | CISPLATIN + RT |
| 330001072 | 330000584 | 1.65 | 85 | Curative (C) | 2014-04-10 | 2014-04-10 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330002689 | CISPLATIN + RT |
| 330001073 | 330000585 | 1.7 | 75.4 | Palliative (P) | null | 2013-10-24 | CISPLATIN + FLUOROURACIL | 2 | null | 330002696 | CISPLATIN + FLUOROURACIL |
| 330001074 | 330000586 | 1.58 | null | Curative (C) | 2015-02-02 | 2015-02-03 | CISPLATIN + RT | N | Y | 330002703 | CISPLATIN + RT |
| 330001075 | 330000587 | 1.7 | 59.1 | Palliative (P) | 2014-11-22 | 2014-11-22 | CISPLATIN + FLUOROURACIL | 2 | N | 330002704 | CISPLATIN + FLUOROURACIL |
| 330001076 | 330000588 | 1.86 | 65.9 | Adjuvant (A) | 2015-06-06 | 2015-06-06 | Cisplatin + Radiotherapy | N | Y | 330002705 | CISPLATIN + RT |
| 330001077 | 330000589 | 1.7 | 81 | Curative (C) | 2014-02-09 | 2014-02-10 | Cisplatin + Radiotherapy | 02 | null | 330002706 | CISPLATIN + RT |
| 330001078 | 330000590 | 1.82 | 125.5 | Curative (C) | 2014-05-30 | 2014-06-11 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330002707 | CISPLATIN + RT |
| 330001079 | 330000591 | 1.55 | 48.6 | null | null | 2015-01-26 | Cisplatin +Fluorouracil (3 wk) | N | N | 330002709 | CISPLATIN + FLUOROURACIL |
| 330001080 | 330000592 | null | 64 | Neo-adjuvant (N) | 2014-11-01 | 2014-11-07 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330002716 | CISPLATIN + FLUOROURACIL |
| 330001081 | 330000593 | 1.56 | 73 | Adjuvant (A) | 2015-01-21 | 2015-02-07 | Cisplatin + Radiotherapy | N | Y | 330002720 | CISPLATIN + RT |
| 330001082 | 330000594 | 1.64 | 47 | Palliative (P) | 2016-01-08 | 2016-01-13 | CISPLATIN + FLUOROURACIL | 02 | null | 330002726 | CISPLATIN + FLUOROURACIL |
| 330001083 | 330006395 | 1.58 | 49 | Neo-adjuvant (N) | 2017-12-05 | 2017-12-29 | Cisplatin +Fluorouracil (3 wk) | N | N | 330002727 | CISPLATIN + FLUOROURACIL |
| 330001084 | 330006395 | 1.66 | 100.7 | Curative (C) | 2017-01-05 | 2017-01-05 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330002727 | NOT MATCHED |
| 330001085 | 330000595 | 1.72 | 108 | null | 2014-06-25 | 2014-07-01 | CNS Headstart II A Ind 1,2,3 int | 2 | N | 330002732 | NOT MATCHED |
| 330001087 | 330000597 | 1.6 | 75 | Curative (C) | null | 2017-05-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330002736 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001088 | 330000597 | 1.62 | null | Curative (C) | 2016-09-25 | 2016-10-19 | Cisplatin | N | Y | 330002736 | CISPLATIN |
| 330001089 | 330000597 | 1.77 | 27.8 | Curative (C) | null | 2018-02-19 | Cisplatin 7 day | N | Y | 330002736 | CISPLATIN |
| 330001090 | 330000597 | null | 12.5 | Disease modification (D) | null | 2015-04-10 | NB Low/Interm risk guidelines Carbo/Etop | Y | N | 330002736 | NOT MATCHED |
| 330001091 | 330000597 | null | 76 | Curative (C) | 2015-04-29 | 2015-04-30 | AML Interim Guidelines | null | N | 330002736 | NOT MATCHED |
| 330001092 | 330000598 | 1.77 | 70.6 | Neo-adjuvant (N) | 2017-01-03 | 2017-01-10 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330002747 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001093 | 330000598 | null | null | Curative (C) | 2017-10-05 | 2017-10-05 | NB HRNBL-1 COJEC Ind COURSE A | Y | Y | 330002747 | NOT MATCHED |
| 330001094 | 330000599 | null | 65.9 | Curative (C) | 2017-04-22 | 2017-04-22 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | 330002757 | NOT MATCHED |
| 330001095 | 330000600 | 1.7 | 15 | Curative (C) | null | 2014-09-06 | Cisplatin | 02 | Y | 330002761 | CISPLATIN |
| 330001096 | 330000601 | 0 | 59 | Curative (C) | 2016-06-23 | 2016-06-23 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330002762 | TRIAL |
| 330001097 | 330000602 | 1.73 | null | null | 2014-04-01 | 2014-04-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330002764 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001098 | 330000602 | null | 63 | Adjuvant (A) | 2014-02-17 | 2014-03-27 | Cisplatin | N | Y | 330002764 | CISPLATIN |
| 330001099 | 330000603 | 1.61 | 6.4 | Adjuvant (A) | null | 2014-03-18 | Cisplatin 7 day | N | N | 330002766 | CISPLATIN |
| 330001100 | 330000604 | 1.8 | null | Adjuvant (A) | 2016-08-06 | 2016-09-06 | Cisplatin | null | Y | 330002771 | CISPLATIN |
| 330001101 | 330000604 | 1.6 | 28 | Curative (C) | 2017-01-24 | 2017-03-05 | Cisplatin | 02 | Y | 330002771 | CISPLATIN |
| 330001102 | 330000604 | 1.67 | 53.8 | Curative (C) | 2015-02-27 | 2015-03-23 | Cisplatin 7 day | null | Y | 330002771 | CISPLATIN |
| 330001103 | 330000605 | 1.6 | 66.8 | Curative (C) | 2017-06-23 | 2017-07-17 | Cisplatin 7 day | N | Y | 330002777 | CISPLATIN |
| 330001104 | 330000606 | null | 22.5 | Curative (C) | 2016-10-11 | 2016-10-14 | Cisplatin 7 day | N | Y | 330002778 | CISPLATIN |
| 330001105 | 330006400 | 1.7 | null | Neo-adjuvant (N) | 2016-11-16 | 2016-11-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330002779 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001106 | 330000607 | 1.7 | null | Curative (C) | 2015-04-19 | 2015-04-19 | Cisplatin | 02 | N | 330002783 | CISPLATIN |
| 330001107 | 330000607 | 1.83 | 47.8 | Curative (C) | 2014-02-03 | 2014-03-08 | Cisplatin | N | N | 330002783 | CISPLATIN |
| 330001108 | 330000607 | 1.67 | 58.4 | Curative (C) | 2017-02-27 | 2017-03-04 | Trial Unspecified | N | N | 330002783 | TRIAL |
| 330001109 | 330000608 | 1.81 | 69.3 | Curative (C) | 2016-07-31 | 2016-08-11 | Rucaparib | null | null | 330002799 | TRIAL |
| 330001110 | 330000609 | 1.62 | 68 | Curative (C) | 2016-09-06 | 2016-09-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330002800 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001111 | 330000610 | 173 | 63 | Palliative (P) | 2013-04-08 | 2013-04-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330002805 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001112 | 330000611 | 1.72 | 80 | Curative (C) | 2016-09-29 | 2016-10-15 | Cisplatin | 02 | Y | 330002807 | CISPLATIN |
| 330001113 | 330000612 | null | 50 | Adjuvant (A) | 2014-09-27 | 2014-09-28 | NB HRNBL-1 COJEC Ind COURSE A | N | Y | 330002809 | NOT MATCHED |
| 330001114 | 330000612 | null | 44.4 | Curative (C) | 2013-03-16 | 2013-03-18 | STS Non-Rhabdo EpSSG 2005 IE | null | N | 330002809 | NOT MATCHED |
| 330001115 | 330000612 | null | 67.9 | Curative (C) | null | 2016-01-15 | Cisplatin | 02 | Y | 330002809 | CISPLATIN |
| 330001116 | 330000612 | 1.58 | 47.49 | null | 2016-06-27 | 2016-06-28 | Cisplatin | N | N | 330002809 | CISPLATIN |
| 330001117 | 330000613 | 1.6 | 82.65 | Curative (C) | 2016-07-14 | 2016-08-15 | Cisplatin | 02 | N | 330002816 | CISPLATIN |
| 330001118 | 330000614 | 0 | 62.8 | Curative (C) | null | 2018-01-22 | Trial Unspecified | Y | null | 330002818 | TRIAL |